Ultralente and Nausea aggravated - a phase IV clinical study of FDA data
Nausea aggravated is reported only by a few people who take Ultralente.
The phase IV clinical study analyzes which people take Ultralente and have Nausea aggravated. It is created by eHealthMe based on reports of 71 people who have side effects while taking Ultralente from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
71 people reported to have side effects when taking Ultralente.
Among them, 3 people (4.23%) have Nausea aggravated.
What is Ultralente?
Ultralente has active ingredients of insulin zinc susp extended purified beef. eHealthMe is studying from 72 Ultralente users for its effectiveness, alternative drugs and more.
What is Nausea aggravated?
Nausea aggravated (worse urge to vomit) is found to be associated with 1,470 drugs and 817 conditions by eHealthMe.
Number of Ultralente and Nausea aggravated reports submitted per year:
Gender of people who have Nausea aggravated when taking Ultralente*:
Age of people who have Nausea aggravated when taking Ultralente *:
Common drugs people take besides Ultralente *:
Common side effects people have besides Nausea aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Ultralente and have Nausea aggravated?Check whether Nausea aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Nausea aggravated and when was it recovered:
Expand to all the drugs that have ingredients of insulin zinc susp extended purified beef:
Alternative drugs to, pros and cons of Ultralente:
- Ultralente (72 reports)
Nausea aggravated treatments and more:
- Nausea aggravated (214 reports)
COVID vaccines that are related to Nausea aggravated:
- Nausea aggravated in Moderna COVID Vaccine
- Nausea aggravated in Pfizer BioNTech Covid Vaccine
- Nausea aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Nausea aggravated:
- Prednisone: 33,358 reports
- Methotrexate: 32,398 reports
- Aspirin: 29,615 reports
- Humira: 27,975 reports
- Metformin: 27,632 reports
- Enbrel: 22,001 reports
- Omeprazole: 20,785 reports
- Otezla: 19,636 reports
- Lisinopril: 19,012 reports
- Synthroid: 17,670 reports
All the drugs that are associated with Nausea aggravated:
- Nausea aggravated (1,470 drugs)
Common conditions associated with Nausea aggravated:
- Rheumatoid arthritis: 36,351 reports
- Multiple sclerosis: 29,202 reports
- Pain: 26,819 reports
- High blood pressure: 26,662 reports
- Type 2 diabetes: 25,209 reports
- Depression: 23,325 reports
- Psoriasis: 17,296 reports
- Osteoporosis: 15,606 reports
- Crohn's disease: 14,704 reports
All the conditions that are associated with Nausea aggravated:
- Nausea aggravated (817 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on insulin zinc susp extended purified beef (the active ingredients of Ultralente) and Ultralente (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Contrave and Arthritis Infective - a second ago
- Xyrem and Mephyton drug interaction - 2 seconds ago
- Levetiracetam and Benign Ovarian Tumor - 4 seconds ago
- Briviact and Levetiracetam drug interaction - 4 seconds ago
- Finasteride and Dayquil drug interaction - 10 seconds ago
- Wellbutrin and Qvar drug interaction - 12 seconds ago
- Chantix and Rash - Child Under 2 Years - 14 seconds ago
- Asa and Eyelid Ptosis - 15 seconds ago
- Zofran and Oxcarbazepine drug interaction - 17 seconds ago
- Bactrim and Zicam drug interaction - 17 seconds ago